SLAC’s Matt Garrett and Susan Simpkins talk about tech transfer that brings innovations from the national lab to the people, including advances for medical...
The process, which also facilitates name changes for religious, marital and other reasons, allows researchers of all genders to own their academic work by...
Q-NEXT will tackle next-generation quantum science challenges through a public-private partnership, ensuring U.S. leadership in an economically crucial arena.
Scientists and engineers in South Korea will soon be using SLAC’s signature high-power radio-frequency amplifiers, called XL4 klystrons, to get the most out of...
More than a dozen energy-storage companies have streamlined access to research facilities and expertise at SLAC under a new cooperative R&D agreement with CalCharge.
SLAC’s Matt Garrett and Susan Simpkins talk about tech transfer that brings innovations from the national lab to the people, including advances for medical devices and self-driving vehicles.
The process, which also facilitates name changes for religious, marital and other reasons, allows researchers of all genders to own their academic work by updating their names on previous publications.
Q-NEXT will tackle next-generation quantum science challenges through a public-private partnership, ensuring U.S. leadership in an economically crucial arena.
The White House announced $50 million in funding for ‘Battery500’, a five year effort, as part of a package of initiatives to accelerate adoption of electric vehicles in the U.S.
Scientists and engineers in South Korea will soon be using SLAC’s signature high-power radio-frequency amplifiers, called XL4 klystrons, to get the most out of their new X-ray laser.
More than a dozen energy-storage companies have streamlined access to research facilities and expertise at SLAC under a new cooperative R&D agreement with CalCharge.
Scientists at Genentech and SLAC have watched a key human protein change from a form that protects cells to one that kills them, providing valuable new insights to cancer research.
Given a year to mature, the Institute for Chemical Biology is relaunching under a new name that better reflects its vision of bringing Stanford's unique interdisciplinary culture to bear at a new frontier of chemistry.
